Physician profile
Mark I Silverstein
NPI 1336193101
$1,154.80
in general payments reported to CMS, 2019-2025
10 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2021: $125 · 2022: $259 · 2023: $28.09 · 2024: $49.52 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $232.80 | 2022 | |
| Medtronic USA, INC. | $222.85 | 2019 | |
| Boston Scientific Corporation | $201.87 | 2024-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Ekosonic, Eluvia |
| Terumo Medical Corporation | $133.35 | 2025 | Azur Cx Detachable |
| Siemens Medical Solutions USA, INC. | $109.91 | 2021 | |
| Philips North America LLC | $77.36 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $75.80 | 2019 | |
| Medtronic, INC. | $59.64 | 2021-2025 | Solitaire X |
| Stryker Corporation | $28.09 | 2023 | Spinejack |
| Cook Medical LLC | $13.13 | 2024 | Zilver Ptx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Silverstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.